WELCOME TO HEP-DART 2025
Hilton Hawaiian Village / Honolulu, Hawaii
7-11 December 2025
We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!
History of HEP-DART: Frontiers in Drug Development for Hepatology
Since its inception in 1995, Hep-DART has provided a cutting-edge platform for tackling challenges in drug development for viral hepatitis and chronic liver disease. Hep-DART has been held in-person every other year at various locations. Hep-DART assembles clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC).